Centessa Pharmaceuticals : 2022 UK Annual Report and Accounts

Registered number: 12973576


CENTESSA PHARMACEUTICALS PLC PARENT


COMPANY FINANCIAL STATEMENTS FOR THE YEAR


ENDED 31... | May 23, 2023

Related Keywords

Altrincham ,Trafford ,United Kingdom ,United States ,American ,America ,Carol Stuckley ,Iqbal Hussain ,Mary Lynne Hedley ,Samarth Kulkarni ,Saurabh Saha ,Brett Zbar ,Robert Mckinnon Califf ,Company Information ,Manufacturing Organization ,Contract Research Organization ,Company Balance Sheet ,Parent Company ,Centessa Pharmaceuticals ,Contract Development ,Nasdaq ,United Kingdom Companies ,Exchange Commission ,Lockbody Technology Platform ,Research Excellence Hub ,American Depositary Shares ,Select Market ,United States Securities ,United Kingdom Companies Act ,Annual Report ,Financial Statements ,Kingdom Statutory Disclosures Relevant ,Non Executive Director ,Arjun Goyal ,Lynne Hedley ,Executive Director ,Autosomal Dominant Polycystic Kidney Disease ,Body Technology Platform ,Chief Executive Officer ,United Kingdom Statutory Strategic Report ,Companies Act ,United Kingdom Statutory Strategic ,Centessa Subsidiaries ,Research Excellence ,Each Research Excellence Hub ,Chief Innovation Officer ,Centessa Pharmaceuticals Plc Stock Exchange ,News ,Information ,Press Release ,Registered ,Centessa ,Pharmaceuticals ,Lc ,Company ,Financial ,Statements ,Or ,The ,Nded Cnta Us1523091007 ,